Edition:
United Kingdom

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

2.78USD
20 Apr 2018
Change (% chg)

-- (--)
Prev Close
$2.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,291
52-wk High
$5.20
52-wk Low
$2.24

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.87 -0.104
Sep '17 0.30 -0.112
Jun '17 0.21 -0.500
Mar '17 0.57 -0.151
FY 2016 Dec '16 0.99 -0.112
Sep '16 1.14 0.104
Jun '16 0.58 -0.173
Mar '16 0.81 -0.061
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.02 32.74
P/E High - Last 5 Yrs. 9.46 293.18 45.72
P/E Low - Last 5 Yrs. 9.46 91.59 24.22
Beta -0.19 0.90 0.88
Price to Sales (TTM) 13.52 110.89 5.71
Price to Book (MRQ) 8.54 13.58 5.37
Price to Tangible Book (MRQ) 8.54 14.04 6.95
Price to Cash Flow (TTM) -- 71.40 23.32
% Owned Institutions 4.64 12.75 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -64.15 399.08 9.21
Sales (TTM) vs TTM 1 Yr. Ago -7.80 78.82 5.69
Sales - 5 Yr. Growth Rate -16.73 32.16 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -189.65 25.00 19.36
EPS (TTM) vs TTM 1 Yr. Ago 1.75 -- --
EPS - 5 Yr. Growth Rate -- 38.99 10.76
Capital Spending - 5 Yr. Growth Rate -59.84 40.29 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.19
Current Ratio (MRQ) 5.16 5.30 2.98
LT Debt to Equity (MRQ) 0.00 22.96 12.18
Total Debt to Equity (MRQ) 0.00 24.62 16.45
Interest Coverage (TTM) -- -99.35 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.02 54.44
Gross Margin - 5 Yr. Avg. -- 51.13 52.20
EBITD Margin (TTM) -195.94 -- --
EBITD - 5 Yr. Avg -377.16 -574.75 10.96
Operating Margin (TTM) -197.09 -718.53 4.73
Operating Margin - 5 Yr. Avg. -320.58 -596.06 6.40
Pre-Tax Margin (TTM) -253.47 -693.00 5.57
Pre-Tax Margin - 5 Yr. Avg. -264.44 -599.42 6.81
Net Profit Margin (TTM) -253.47 -694.22 1.87
Net Profit Margin - 5 Yr. Avg. -264.44 -602.27 3.09
Effective Tax Rate (TTM) -- 22.62 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.21 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 194,134 22,626,821 846,830,978
Net Income/Employee (TTM) -492,081 2,971,371 99,616,195
Receivable Turnover (TTM) 4.40 20.16 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.19 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -48.89 -1.11 10.95
Return on Assets - 5 Yr. Avg. -57.32 -0.57 12.31
Return on Investment (TTM) -119.26 1.58 14.38
Return on Investment - 5 Yr. Avg. -262.99 2.21 16.10
Return on Equity (TTM) -119.07 2.41 16.07
Return on Equity - 5 Yr. Avg. -367.36 3.09 17.39
  1 Year 3 Year 5 Year
Sales % 29.92 -25.44 -16.73
EPS (TTM) % 86.48 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cleveland Biolabs Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.32%
# of Holders: 24
Total Shares Held: 599,956
3 Mo. Net Change: -2,787
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.